Sacroiliac joint fusion is a surgical procedure which fuses the iliac bone (pelvis) to the spine (sacrum) for stabilization. It is performed for a variety of conditions including trauma, infection, cancer, and spinal instability. Sacroiliac joint fusion may be performed as a minimally invasive surgical (MIS) procedure or as an open surgical procedure requiring a larger incision and subsequent increased recovery time.
Percutaneous SIJ fusion is a MIS approach in which instrumentation involving cages or screws, with or without bone graft, are placed percutaneously in order to achieve a fusion. Fusion of the SIJ, combined with bone grafts and other metal implant devices, is an extensive procedure; generally considered a salvage procedure when all other measures have failed to provide pain relief.
According to a recent study GLOBAL MIS SACROILIAC JOINT FUSION MARKET INSIGHTS, FORECAST TO 2025 American is the largest market of MIS Sacroiliac Joint Fusion, with a market share nearly 65% in 2017. Europe is the second largest supplier of MIS Sacroiliac Joint Fusion, enjoying market share nearly 20% in 2017.
TheGlobal MIS Sacroiliac Joint Fusion market is valued at 150 million US$ in 2018 and will reach 450 million US$ by the end of 2025, growing at a CAGR of 14.7% during 2019-2025.
This market has experienced rapid growth as a result of :
- Reimbursement policy changes
- New product entrants.
- Increasing an awareness of SI joint dysfunction and improvements in diagnostic processes.
Which are the 25 main players? Please visit: http://www.thespinemarketgroup.com/category/si-joint-fusion/